1. Home
  2. CGTX vs OPHC Comparison

CGTX vs OPHC Comparison

Compare CGTX & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • OPHC
  • Stock Information
  • Founded
  • CGTX 2007
  • OPHC 2000
  • Country
  • CGTX United States
  • OPHC United States
  • Employees
  • CGTX N/A
  • OPHC N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • OPHC Major Banks
  • Sector
  • CGTX Health Care
  • OPHC Finance
  • Exchange
  • CGTX Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • CGTX 53.4M
  • OPHC 51.8M
  • IPO Year
  • CGTX 2021
  • OPHC N/A
  • Fundamental
  • Price
  • CGTX $2.41
  • OPHC $4.27
  • Analyst Decision
  • CGTX Strong Buy
  • OPHC
  • Analyst Count
  • CGTX 3
  • OPHC 0
  • Target Price
  • CGTX $2.83
  • OPHC N/A
  • AVG Volume (30 Days)
  • CGTX 12.4M
  • OPHC 15.3K
  • Earning Date
  • CGTX 08-07-2025
  • OPHC 11-07-2025
  • Dividend Yield
  • CGTX N/A
  • OPHC N/A
  • EPS Growth
  • CGTX N/A
  • OPHC 6.01
  • EPS
  • CGTX N/A
  • OPHC 1.28
  • Revenue
  • CGTX N/A
  • OPHC $41,269,000.00
  • Revenue This Year
  • CGTX N/A
  • OPHC N/A
  • Revenue Next Year
  • CGTX N/A
  • OPHC N/A
  • P/E Ratio
  • CGTX N/A
  • OPHC $3.32
  • Revenue Growth
  • CGTX N/A
  • OPHC 36.79
  • 52 Week Low
  • CGTX $0.22
  • OPHC $3.53
  • 52 Week High
  • CGTX $3.83
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 61.15
  • OPHC 44.96
  • Support Level
  • CGTX $2.26
  • OPHC $4.21
  • Resistance Level
  • CGTX $2.67
  • OPHC $4.42
  • Average True Range (ATR)
  • CGTX 0.40
  • OPHC 0.06
  • MACD
  • CGTX -0.03
  • OPHC 0.00
  • Stochastic Oscillator
  • CGTX 42.08
  • OPHC 26.19

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: